Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus

Lupus

Volumn 24, Issue 6, 2015, Pages 606-612

  Garcia Carrasco M ^a,b   Mendoza Pinto, C ^a,b   Munguia Realpozo P ^a   Rodriguez Gallegos A ^c   Vallejo Ruiz, V ^a   Munoz Guarneros M ^b   Mendez Martinez S ^a   Soto Santillan P ^a   Pezzat Said, E ^b   Reyes Leyva, J ^a   Lopez Colombo A ^a   Ruiz Arguelles A ^c   Cervera, Ricard ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c Laboratorios Clinicos de Puebla   (Mexico)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Cervical human papillomavirus infection; systemic lupus erythematosus; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PREDNISONE; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; AGE; ARTICLE; CERVICAL HUMAN PAPILLOMAVIRUS INFECTION; CHEMILUMINESCENCE IMMUNOASSAY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CYTOLOGY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; IMMUNOASSAY; LONGITUDINAL STUDY; MIDDLE AGED; PREVALENCE; PROCEDURES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; IMMUNOASSAY; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84928041975     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314559628     Document Type: Article

References (45)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
2. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol. 2012 ; 76: 315-325
3. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: A helpful immuno-modulator. Immunology. 2011 ; 134: 123-139
4. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player?. Best Pract Res Clin Endocrinol Metab. 2011 ; 25: 617-632
5. Khoo LA, Chai L, Koenen H, Joosten I, Netea M, van der Ven A. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol. 2012 ; 38: 122-135
6. Hewison M. Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am. 2010 ; 39: 365-379
7. Deluca HF, Cantorna MI. Vitamin D: Its role and uses in immunology. FASEB J. 2001 ; 15: 2579-2585
8. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: A systemic review of randomized controlled trials. Endocr Pract. 2009 ; 15: 438-449
9. Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review. Aust N Z J Obstet Gynaecol. 2011 ; 51: 103-108
10. Kim SC, Glynn RJ, Giovannucci E, et al. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: A population-based cohort study. Ann Rheum Dis. Epub ahead of print 11 March 2014. DOI: 10.1136/annrheumdis-2013-204993.
11. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008 ; 47: 920-923
12. Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol. 2001 ; 60: 352-358.
13. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009 ; 20: 427-433
14. Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157
15. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus. 2011 ; 20: 1155-1160
16. Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010 ; 19: 13-19
17. Tam LS, Chan AY, Chan PK, Chang AR, Li EK. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: Association with human papillomavirus infection. Arthritis Rheum. 2004 ; 50: 3619-3625
18. Nath R, Mant C, Luxton J, et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum. 2007 ; 57: 619-625
19. Rojo-Contreras W, Olivar-Flores EM, Gamez-Nava JI, et al. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis. Lupus. 2012 ; 21: 365-372
20. Lyrio LD, Grassi MF, Santana IU, et al. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus. Rheumatol Int. 2013 ; 33: 631-636
21. Tam LS, Chan PK, Ho SC, et al. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol. 2010 ; 37: 330-340
22. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725
24. Guzman J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol. 1992 ; 19: 1551-1558
25. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA. 2002 ; 287: 2114-2119
26. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000 ; 38: 357-361
27. van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990 ; 28: 2739-2743
28. Yasojima K, Kilgore KS, Washington RA, Lucchesi BR, McGeer PL. Complement gene expression by rabbit heart: Upregulation by ischemia and reperfusion. Circ Res. 1998 ; 82: 1224-1230
29. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 ; 348: 518-527
30. Wu PW, Rhew EY, Dyer AR, et al. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1387-1395
31. Henry HL, Bouillon R, Norman AW, et al. 14th vitamin D workshops consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2010 ; 121: 4-6
32. IOM. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: National Academy Press ; 2011: 13-14.
33. Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal and others cancers. J Photochem Photobiol B. 2010 ; 101: 130-136
34. Parkin M. Global cancer statistics in the year 2000. Lancet Oncol. 2001 ; 2: 533-543
35. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 ; 55: 244-265
36. Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk?. Nat Rev Cancer. 2002 ; 2: 694-704
37. Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukocyte Biol. 2002 ; 71: 16-32
38. Chih HJ, Lee AH, Colville L, Binns CW, Xu D. A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical intraepithelial neoplasia. Nutr Cancer. 2013 ; 65: 317-328
39. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002 ; 2: 342-350
40. Luong KVQ, Nguyen LTH. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol. 2010 ; 73: 192-201
41. Klumb EM, Pinto AC, Jesus GR, et al. Are women with lupus at higher risk of HPV infection?. Lupus. 2010 ; 19: 1485-1491
42. Borella E, Nesher G, Shoenfeld Y. Vitamin D: A new anti-infective agent? Ann N Y Acad Sci. 2014; 1317: 76-83.
43. Shulte-Uebbing C, Schlett S, Craiut ID, Antal L, Olah H. Chronic cervical infections and dysplasia (CIN I, CIN II): Vaginal vitamin D (high dose) treatment. Dermatoendocrinology. 2014 ; 6: e27791
44. Hosono S, Matsuo K, Kajiyama H, et al. Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. European J Clin Nutr. 2010 ; 64: 400-409
45. Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer. 2003 ; 106: 396-403